Interim Results from Week 26 Semaglutide Alone Total Weight Loss: 23 lb Lean Mass Loss: 34.5% (~7.9 lb) Fat Mass Loss: 66.3% Low-Dose Combo (Semaglutide + Low Trevogrumab) Total Weight Loss: 21.6 lb Lean Mass Loss: ~17% (~3.7 lb) Fat Mass Loss: 78.1% Lean Mass Preserved: ~50.8% vs semaglutide alone High-Dose Combo (Semaglutide + High Trevogrumab) Total Weight Loss: 24.8 lb Lean Mass Loss: ~16.8% (~4.2 lb) Fat Mass Loss: 76.3% Lean Mass Preserved: ~51.3% vs semaglutide alone Triplet Combo (Semaglutide + High Trevogrumab + Garetosmab) Total Weight Loss: 30 lb Lean Mass Loss: ~6.6% (~2.0 lb) Fat Mass Loss: 84.4% Lean Mass Preserved: ~80.9% vs semaglutide alone Key insight : All combo treatments preserved significantly more lean mass and enhanced fat loss compared to semaglutide alone
Therefore, lifestyle and pharmacological options must be evaluated to improve or prevent those obesity underlying pathologies
Read reference All compounds listed are intended strictly for laboratory research purposes no medical claims, no therapeutic guarantees
This combination makes yoga particularly helpful if high-intensity exercise feels overwhelming or triggers your anxiety
Arrange a routine appointment with your GP or diabetes nurse if: Injection site reactions persist beyond one week or worsen progressively You develop a mild rash that does not resolve within a few days Skin changes cause concern or uncertainty about continuing treatment You experience persistent itching without visible rash When consulting your healthcare provider, provide comprehensive information including when the skin changes began, their location and appearance, any associated symptoms, and whether you have started any other new medications or products
Continue onto I-83BUS N/S George St
